MedPath

Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures

Completed
Conditions
Chronic Heart Failure
Interventions
Procedure: Epicardial left ventricular lead placement
Procedure: Transvenous left ventricular lead implant
Registration Number
NCT00288288
Lead Sponsor
University of Kansas
Brief Summary

The primary purpose of this study is to compare the time, risk and cost savings of 2 patient groups who receive FDA approved left ventricular pacing leads.

Detailed Description

The purpose of this study is to: a) examine the usefulness of placing an epicardial LV lead at the time of open chest surgery in patients who are likely to benefit from a CRT system following their surgery; b) compare differences between patients who receive LV leads using the transvenous approach and those patients who receive LV leads using the epicardial approach; and c) assess the cost effectiveness of placing the LV lead via the transvenous versus the epicardial approaches.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Left ventricular ejection fraction < or = 35%
  2. QRS duration greater than or = to 120ms
  3. NYHA Functional Class 3 or 4
  4. Age > or = to 18 years
Exclusion Criteria
  1. No previous pacemaker or ICD implant
  2. No permanent atrial fibrillation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Epicardial left ventricular lead placementEpicardial left ventricular lead placement during a clinically indicated open chest surgery
2Transvenous left ventricular lead implantTransvenous left ventricular lead implant during a clinically indicated CRT system implant
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath